RenovoRx, Inc. RNXT
At closeNov 10, 2026, 8:19 AM EST
Pre-market · Nov 10, 8:19 AM ET
- YTD
- +40.48%
- 1 year
- +22.66%
Discussion (77)
Sign in to join the discussion
This catheter can be used for all kinds of cancer, pancreatic was a smart move
Oh wow … this drug/catheter combo prolongs life of cancer patients by 1.5 year
Oh more sweet news, this company is prolonging cancer patient’s lives, shorts have no clue.
Shorts are like cockroaches, they walk in the dark and get step over by longs.
$10 today easy money
Shorts playing Russian roulette with $65M market cap biotech ?
Don’t sell , you will be sorry later
This drug/catheter combo can extend the life of people with pancreatic cancer, why would anyone want to destroy this company. Shorts don’t give a shit!
IPO price was $14 about 2 months ago, shorts pulled down RNXT to $5, so time to bounce back to $25. This company has huge potential.
Just remember IPO was priced at $14 just 2 months ago. Stock opened $16 and drifted $5 by shorts, now pay time.
